Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-yr follow-up.
about
Physical inactivity: a risk factor and target for intervention in renal care.Primary care of the renal transplant patient.Death with functioning kidney transplant: an obituarial analysisLow physical activity and risk of cardiovascular and all-cause mortality in renal transplant recipients.The transplant patient and transplant medicine in family practiceAssessment and management of hypertension in transplant patientsReverse epidemiology: a spurious hypothesis or a hardcore reality?Fear of Movement and Low Self-Efficacy Are Important Barriers in Physical Activity after Renal TransplantationAssessment of Arterial Stiffness, Volume, and Nutritional Status in Stable Renal Transplant Recipients.Does African American Race Impact Statin Efficacy in Renal Transplant Outcomes?Toxicity spectrum of inhibitors of mammalian target of rapamycin in organ transplantation: etiology, pathogenesis and treatment.Inhibition of the mTOR pathway: a possible protective role in coronary artery disease.Cardiac imaging for the assessment of patients being evaluated for kidney or liver transplantation.The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes.Long-term outcomes and transmission rates in hepatitis C virus-positive donor to hepatitis C virus-negative kidney transplant recipients: Analysis of United States national data.Safety and efficacy of administering the maximal dose of candesartan in renal transplant recipients.Long-term cardiovascular outcomes in type 1 diabetic patients after simultaneous pancreas and kidney transplantation compared with living donor kidney transplantation.Retroactive application of the new kidney allocation system to renal transplants performed in the ECD/SCD era.Dietary protein, blood pressure and renal function in renal transplant recipients.Postoperative outcomes and management strategies for coronary artery disease in patients in need of a lung transplantation.Impact of calcineurin-inhibitor conversion to mTOR inhibitor on renal allograft function in a prednisone-free regimen.Atrial fibrillation in kidney transplant recipients: is there a place for the novel drugs?The association of physical function and physical activity with all-cause mortality and adverse clinical outcomes in nondialysis chronic kidney disease: a systematic review
P2860
Q30238711-1100BBE6-B2D9-457C-8118-36B5070E4575Q33898744-ECD89F09-54C5-4CDD-8F78-785319089911Q34368831-FC608131-45C2-453B-8E1B-4717D3AADE9AQ34751949-573DECF6-2C2E-4A7C-9D1E-767A0969722EQ35029807-CADA09C3-58A5-43BD-8D85-F6A1A5CF029FQ35658644-3CF76D2A-E8E9-4227-AD9A-93AEBF59A175Q35997678-4288CC92-DA76-4AB0-83F6-D3E945722583Q36547620-8B87072E-3CDF-4582-90B4-3878AE1E9C8DQ36581199-71E6DA39-E337-433A-AA75-49D3AEA3BB64Q37226086-22D913A9-10C8-46FE-9B69-5E47609BB758Q37873950-0BCFB077-0B75-4476-804A-033D3564419DQ38106486-D52DDD9B-7A17-441C-A1F9-2D294EB59A58Q38258031-2C3936CB-9373-49CA-8635-90F733F40FCEQ38496715-A4133256-04FA-4544-B85C-D44034206FFCQ38677150-4F0BFB3E-0547-4ED8-8158-1C47D8C6C2F8Q39720848-836A83FE-31D4-4285-B9CD-F49D8599389EQ40162549-22FEC960-5147-4966-AEB1-D90E6A4AE3FDQ45020147-EC6F1D2C-43E9-4DCD-A0E2-F3E04932A4C1Q46378621-796525B3-6F5E-4835-925A-0D5F847C6F36Q48208442-62D99104-574F-4144-AF7E-39F42015BDF1Q54411021-025978B1-4A84-4750-8ACF-A70D1B189CBAQ54720771-BE7FAE0C-59E3-4878-ABF7-AA703D4CD340Q58568715-0BA65156-4702-4DFA-ACEB-49943C770481
P2860
Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-yr follow-up.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Cardiovascular disease in stab ...... ality during a 5-yr follow-up.
@en
type
label
Cardiovascular disease in stab ...... ality during a 5-yr follow-up.
@en
prefLabel
Cardiovascular disease in stab ...... ality during a 5-yr follow-up.
@en
P2093
P2860
P1476
Cardiovascular disease in stab ...... ality during a 5-yr follow-up.
@en
P2093
Ketil Dahl
Svend Aakhus
Tor Erik Widerøe
P2860
P304
P356
10.1111/J.1399-0012.2004.00235.X
P577
2004-10-01T00:00:00Z